StonvexLoading…
StonvexStonvexStonvexCore line items from REBN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.09M | $2.60M | $1.11M | $3.18M |
Operating Income | $-2.88M | $-2.15M | $-951.96K | $-3.54M |
Net Income | $-3.01M | $-1.29M | $-964.16K | $-3.55M |
EPS (Diluted) | $-1.82 | $-1.37 | $-0.63 | $-0.29 |
Total Assets | $8.44M | $12.06M | $8.16M | $8.46M |
Total Liabilities | $6.88M | $9.78M | $4.84M | $4.17M |
Cash & Equivalents | $363.95K | $337.49K | $873.10K | $3.02M |
Free Cash Flow OCF − CapEx | $-3.74M | $-6.70M | $-2.13M | $-3.98M |
Shares Outstanding | 13.26M | 13.21M | 13.16M | 13.16M |